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AbsTrACT 
background Successful non-operative management 
(NOM) of blunt splenic trauma is enhanced with splenic 
angioembolization (SAE). Patients may still require 
splenectomy post-SAE for splenic infarction/necrosis. 
Prior studies have used white blood cell count (WBC), 
platelet count (PLT), and PLT:WBC ratio after splenectomy 
to predict complications, but none have evaluated these 
findings prior to splenectomy in patients who have 
undergone SAE. Changes in these values may indicate 
clinically significant splenic infarction, facilitating 
management of these patients.
Methods Patients admitted to an American College 
of Surgeons verified level 1 trauma center from January 
2007 to August 2017 who underwent SAE were 
identified. Patients with successful NOM after SAE (SAE/
NOM) were compared with those requiring splenectomy 
(SAE/SPLEN). Data included demographics, splenic 
injury grade, Injury Severity Score (ISS), time to SAE and 
splenectomy, intensive care unit and hospital length of 
stay (LOS), and complete blood count. Lab values were 
analyzed immediately post-SAE (time 1) and day 5 post-
SAE (or day of discharge) for SAE/NOM patients and day 
of SPLEN for SAE/SPLEN patients (time 2). Data were 
analyzed using Mann-Whitney U, χ2 tests, and receiver 
operating characteristic (ROC) curves with significance 
attributed to P<0.05.
results Of 124 patients undergoing SAE, 16 (13%) 
later required SPLEN for infarction/necrosis at a median 
of 5 days post-SAE (IQR: 3–10 days). SAE/SPLEN and 
SAE/NOM patients did not differ by age, gender, ISS, or 
grade of splenic injury. SAE/SPLEN patients had longer 
hospital LOS (23 vs. 10 days, P<0.001). WBC, PLT, and 
PLT:WBC ratio did not differ between the groups at time 
1. At time 2, WBC was higher and PLT:WBC ratio was 
lower in SAE/SPLEN patients. Using ROC curves at time 
2, the area under the curve was 0.90 (P<0.001) for WBC 
and 0.71 (P<0.007) for PLT:WBC ratio.
Discussion Patients requiring splenectomy for 
clinically significant infarction/necrosis after SAE 
develop leukocytosis and decreased PLT:WBC ratio when 
compared with SAE/NOM patients. Monitoring these 
parameters allows more prompt diagnosis and operative 
intervention.
Level of evidence Therapeutic/care management, 
level III.
bACkgrounD
Successful non-operative management (NOM) of 
blunt splenic trauma has increased with the use of 
splenic angioembolization (SAE).1–6 The reported 
splenectomy rate for hemorrhage after SAE is 
about 3% to 22%.2 4 However, patients may still 
require splenectomy post-SAE due to symptomatic 
splenic infarction and necrosis. To our knowledge, 
this specific scenario has not been studied. Prompt 
recognition of these non-hemorrhagic complica-
tions can be challenging due to the non-specific 
symptoms of fever, abdominal pain, and tachy-
cardia. Trends in white blood cell count (WBC), 
platelet count (PLT), and PLT:WBC ratio have been 
previously described for identifying patients with 
infection after splenectomy.7–9 However, no studies 
have evaluated symptomatic splenic infarction and 
necrosis using these findings prior to splenectomy 
in patients who have undergone SAE. We theorized 
that the alterations in these values may indicate 
clinically significant splenic infarction and thus 
facilitate the management of these patients.
MeThoDs
Patients with blunt splenic injury admitted to 
Community Regional Medical Center, an American 
College of Surgeons-verified level 1 trauma center 
in Fresno, California, between 1 January 2007 and 
31 August 2017, made up the study population. 
Patients were identified from the trauma registry 
and included if SAE was performed. Exclusion 
criteria were post-SAE splenectomy for hemor-
rhage, and preinjury splenomegaly or leukocytosis 
due to malignancy. Data included demographics, 
splenic injury grade, Injury Severity Score (ISS), 
time to SAE and splenectomy, intensive care unit 
and hospital length of stay (LOS), and laboratory 
studies. Complete blood count and PLT count 
values were noted immediately post-SAE, then 
daily, until discharge for SAE/NOM patients or 
splenectomy for SAE/SPLEN patients. Values imme-
diately post-SAE were defined as time 1. Time 2 was 
defined as day 5 post-SAE (or day of discharge) for 
SAE/NOM patients and preoperatively on the day 
of splenectomy for SAE/SPLEN patients. Patients 
with successful NOM after SAE (SAE/NOM) were 
compared with those who required splenectomy for 
symptomatic infarction or necrosis (SAE/SPLEN). 
Patient records were reviewed for indications for 
splenectomy, operative findings, cultures of splenic 
tissue (if done), and pathologic reports. Postembo-
lization CT scans were done at the discretion of the 
attending surgeon, and indications and results from 
these scans were reviewed.
Initial evaluation of appropriate, hemodynam-
ically stable patients with blunt trauma was with 
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contrast-enhanced CT scans. A 64-slice CT scanner (GE) was 
used at our institution between 2007 and 2013, and a 320-slice 
scanner (Toshiba) has been in use from 2013 to the present. SAE 
was performed if there was a visible splenic ‘blush’ or pseudo-
aneurysm visible on the admission CT. SAE was also performed 
for some patients with American Association for the Surgery 
of Trauma grade 4 and 5 splenic injuries per attending surgeon 
choice. SAE included both proximal and distal embolization. 
The technique for both proximal and distal SAE has been previ-
ously described in the literature.10 11
Statistical analyses were performed using the Statistical 
Package for Social Sciences (IBM SPSS Statistics for Windows, 
V.23.0). Data were analyzed using Mann-Whitney U, Χ2 tests, 
and receiver operating characteristic (ROC) curves with signifi-
cance attributed to P<0.05.
resuLTs
During the 10.5-year study period, 40 591 patients were 
included in the trauma registry, with 30 974 having blunt mecha-
nism (76%). Blunt splenic injury was identified in 1218 patients, 
129 of whom underwent SAE. Of these, five were excluded: two 
due to post-SAE hemorrhage; one because of pretrauma spleno-
megaly and a WBC >100 000/µL due to leukemia; one patient 
had splenectomy over 6 months after SAE for a symptomatic, 
sterile splenic cyst; and one patient was excluded due to place-
ment of a pigtail catheter in a splenic abscess by interventional 
radiology 1 month after initial discharge.
There were 124 patients included in the study, 108 with no 
intervention after SAE and 16 (13%) later requiring splenectomy 
for symptomatic infarction and necrosis, at a median of 5 days 
post-SAE (IQR: 3–10 days). SAE/SPLEN and SAE/NOM patients 
did not differ by age, gender, ISS, or grade of splenic injury 
(table 1). However, SAE/SPLEN patients had longer hospital 
LOS compared with SAE/NOM. There was no significant differ-
ence in the use of proximal versus distal embolization between 
the two groups (P=0.41; see table 1).
Comparisons of mean WBC and PLT:WBC are shown in 
figures 1 and 2. WBC, PLT, and PLT:WBC ratio did not differ 
between the groups at time 1. At time 2, WBC (103/μL) was 
significantly higher (22±6 vs. 12±4, P<0.001) and PLT:WBC 
ratio was significantly lower (16±7 vs. 23±15, P=0.007) in the 
SAE/SPLEN patients (table 2).
ROC curves indicated that WBC had an area under the curve 
(AUC) of 0.90 (P<0.001) for predicting splenectomy (figure 3) 
with a threshold of >15 000/µL (sensitivity=0.81, speci-
ficity=0.81). The PLT:WBC ratio had an AUC of 0.71 (P=0.007) 
for predicting splenectomy, with an optimal threshold of <15 
(sensitivity=0.75, specificity=0.69) (figure 4).
In all the patients who underwent splenectomy, unremitting 
abdominal pain, persistent fever, leukocytosis, and tachycardia 
were the primary reasons for post-SAE CT scanning. Signifi-
cant splenic infarction and necrosis on post-SAE CT scan was 
an indication for operation. Seven of the SAE/SPLEN patients 
had moderate to large left pleural effusions. Five had small left 
pleural effusions. Four patients had no detectable left pleural 
effusion, three of whom had left chest tubes placed during their 
initial resuscitation. There were no documented concomitant or 
alternative intraoperative reasons for laparotomy documented 
in the SPLEN group, such as missed hollow visceral injuries or 
significant mesenteric injuries.
Review of the CT scans of the SAE/SPLEN patients demon-
strated that all had at least 50% infarction or more of the spleen in 
all patients. The degree of infarction and necrosis was quantified 
Table 1 Patient characteristics
sAe/noM
(n=108)
sAe/sPLen
(n=16) P value
Age 40±19 46±15 0.16
Male gender 74 (68%) 9 (56%) 0.33
ISS 23±10 21±14 0.40
Splenic injury grade 
  1 9 (8%) 1 (6%) 1.00
  2 14 (13%) 3 (19%) 0.46 
  3 34 (32%) 6 (38%) 0.63 
  4 41 (38%) 4 (25%) 0.31 
  5 10 (9%) 2 (12%) 0.65 
Distal angioembolization 87 (81%) 14 (88%) 0.41
ICU admission 46 (43%) 11 (69%) 0.05
Hospital length of stay (days) 10±11 23±19 <0.001
ICU, intensive care unit; ISS, Injury Severity Score; SAE/NOM, successful non-
operative management after splenic angioembolization; SAE/SPLEN, splenectomy 
after splenic angioembolization.
Figure 1 Comparison of white blood cell count (WBC). SAE/NOM, 
successful non-operative management after splenic angioembolization; 
SAE/SPLEN, splenectomy after splenic angioembolization. 
Figure 2 Comparison of PLT:WBC. SAE/NOM, successful non-operative 
management after splenic angioembolization; SAE/SPLEN, splenectomy 
after splenic angioembolization; PLT:WBC, ratio of platelet count to 
white blood cell count.
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on only 2 of the 16 CT radiology reports of the SPLEN patients 
(‘complete splenic infarction’ and ‘75% infarction’). Seven of the 
16 (44%) of the SAE/SPLEN patients had air visualized within 
the parenchyma of the spleen on the postembolization CT scan. 
In the SAE/NOM patients, 12 of the 46 patients who had a post-
embolization CT scan (26%) had air noted within the spleen. All 
patients who had splenic air on CT had Gelfoam used in their 
SAE.
The pathologic reports of the removed spleens described 
unquantified degrees and combinations of the following: ‘hemor-
rhagic necrosis’, ‘inflammation’, ‘infarct’, ‘multiple infarcts’, 
‘recent hemorrhage with necrosis’, ‘ischemia’, and ‘acute inflam-
mation’. No cultures of the splenic tissue from the splenectomy 
specimens were performed.
DisCussion
SAE has enhanced NOM of blunt splenic injuries,1–6 but 
non-hemorrhagic complications of infarction and necrosis of 
the spleen can still occur as a result.12–15 The SAE/NOM patients 
in our study represent a specific subset of patients who have 
non-specific symptoms such as fever and abdominal pain, as well 
as the associated findings of tachycardia and leukocytosis related 
to the splenic embolization. CT scan of the abdomen in these 
symptomatic, post-SAE patients will invariably demonstrate 
some degree of infarction of the spleen along with some areas 
of perfusion, as well as areas of air within the splenic paren-
chyma when Gelfoam is used.12–14 The purpose of our study was 
to investigate whether objective laboratory values could help 
with the management of symptomatic post-SAE patients whose 
splenic infarction has impelled clinical concern.
Splenectomy for symptomatic infarction and necrosis appears 
to occur infrequently, as it took over 10 years of chart review to 
obtain 16 cases. Although this complication is not common, it 
can be quite challenging to manage when it does occur, as this 
subset of SAE patients who neither immediately recover or prog-
ress to hemorrhage and urgent splenectomy appear to ‘smolder’ 
in the hospital. Fevers, tachycardia, ileus, concerning leukocy-
tosis, or unremitting abdominal discomfort appear to plague this 
group of patients who fails to definitively recuperate from blunt 
splenic injury after embolization.
WBC count and PLT count have been used to help differ-
entiate between infection and the normal leukemoid response 
to splenectomy.7–9 Using these same parameters seemed to be a 
logical step in the management of post-SAE patients. Specific CT 
findings after splenic embolization, including infarcts, have been 
described in 63% of patients after proximal embolization and up 
to 100% after distal embolization.12–14 However, the specific clin-
ical context, such as symptoms or clinical findings, has not been 
defined. The studies by Ekeh et al13 and Wu et al14 also describe 
CT findings after SAE but without detailing clinical findings or 
symptoms related to each of the scans. Haan et al1 described 
low-grade fever or left upper quadrant pain as ‘minimal symp-
toms’ in SAE/NOM patients seen in follow-up who were treated 
Table 2 Patient outcomes
sAe/noM
(n=108)
sAe/sPLen
(n=16) P value
Time 1 
  WBC (103/µL) 17±12 17±5 0.21 
  PLT (103/µL) 191±65 189±64 0.85 
  PLT:WBC 14±6 12±6 0.21 
Time 2 
  WBC (103/µL) 12±4 22±6 <0.001 
  PLT (103/µL) 244±108 334±187 0.096 
  PLT:WBC 23±15 16±7 0.007 
PLT, platelet count; PLT:WBC, ratio of PLT count to WBC count; SAE/NOM, successful 
non-operative management after splenic angioembolization; SAE/SPLEN, 
splenectomy after splenic angioembolization; Time 1, immediately after splenic 
angioembolization; Time 2, day 5 post-SAE or day of discharge for SAE/NOM, day of 
splenectomy for SAE/SPLEN; WBC, white blood cell count. 
Figure 3 Receiver operating characteristic curve of white blood cell 
count for outcome of splenectomy.
Figure 4 Receiver operating characteristic curve of PLT:WBC ratio 
for outcome of splenectomy. PLT:WBC, ratio of platelet count to white 
blood cell count. 
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expectantly with analgesics and two patients with ‘large, symp-
tomatic’ splenic infarcts with air on follow-up CT who required 
splenectomy. Cultures taken from the two removed spleens at 
time of operation grew no organisms.1
Our study focused on inpatients who had clinically significant 
and symptomatic post-SAE infarction and necrosis. Weng et al and 
Toutouzas et al7 9 found that postoperative day 5 after splenec-
tomy was the mean time that patients with documented infection 
had a significant increase in their WBC to >15 000 and decrease 
in PLT:WBC ratio <15. In the present study, the median day of 
splenectomy after angioembolization was day 5 in the SAE/SPLEN 
group (time 2). Time 2 was therefore designated as day 5 in the 
SAE/NOM patients. Some of our NOM patients were discharged 
sooner than post-SAE day 5; thus, data from the day of discharge 
were included as time 2 for these SAE/NOM patients.
Review of the CT scans of our SAE/SPLEN patients demon-
strated that all had at least 50% infarction of the spleen. Haan 
et al1 defined a significant infarction as greater than 25% of the 
spleen. In the present study, the degree of infarction and necrosis 
was quantified on only 2 of the 16 CT radiology reports of the 
SPLEN patients (‘complete splenic infarction’ and ‘75% infarc-
tion’). Most of the reports used qualitative terms such as ‘exten-
sive infarct’, ‘extensive necrosis’, and ‘diffuse infarction’. There 
was no significant difference in the use of proximal versus distal 
embolization technique between the two groups. The systemic 
review and meta-analysis by Schnüriger et al15 also noted that 
both techniques had an equivalent rate of major infarctions and 
infections requiring splenectomy.
Our study supports the use of WBC greater than 15 000 in 
symptomatic post-SAE patients who have ongoing abdominal 
pain, fever, and tachycardia as an indication for splenectomy. 
The AUC analysis demonstrates WBC threshold greater than 
15 000 (sensitivity=0.81, specificity=0.81) and PLT:WBC ratio 
threshold less than 15 (sensitivity=0.75, specificity=0.7) as the 
peak areas of each curve, respectively. However, WBC appeared 
to be the more sensitive and specific marker of symptomatic 
splenic infarction requiring splenectomy. Although a WBC of 
15 000 is at the ‘peak’ of the ROC curve, a WBC of greater than 
17 000 has a specificity of about 90% and therefore a lower 
false-positive rate compared with 15 000.
PLT count by itself did not appear to have a useful correlation 
in helping define SAE patients who would require splenectomy. 
Increasing WBC (the denominator) is the driving force that 
decreases the PLT:WBC ratio, not the decrease in PLT count. 
This result is similar to that in the study by Banerjee et al,8 in 
which splenectomy patients who developed postoperative infec-
tion had a lack of significant PLT elevation.
The presence of intraparenchymal splenic air after embolization 
with Gelfoam has been previously described.9 The fact that both 
groups had air noted in the spleen supports the argument that it was 
NOT the presence of gas in the spleen on CT per se that compelled 
the operation but the degree of leukocytosis and infarction.
This study is prone to the weaknesses of retrospective reviews, 
including the fact that attending surgeons were not blinded to 
the laboratory values (WBC, PLT) analyzed in this investiga-
tion, and these observed results were included in the decision to 
perform splenectomy.
In conclusion, a small proportion of patients with blunt splenic 
injury who undergo SAE will require splenectomy for clinically 
important splenic infarction/necrosis. These patients have signifi-
cant leukocytosis and decreased PLT:WBC ratio when compared 
with patients with successful SAE/NOM. Post-SAE patients who 
have persistent tachycardia, abdominal pain, fever, WBC greater 
than 15 000, and/or PLT:WBC ratio less than 15 should get a CT 
scan of the abdomen and are likely to require splenectomy for 
resolution of symptoms. Monitoring these parameters allows more 
prompt diagnosis and operative intervention.
Contributors JFB: study design, literature search, data collection, data analysis, 
data interpretation, writing, critical revision. VLS: study design, literature search, data 
collection, data interpretation. RCD: study design, data collection, data analysis, data 
interpretation. KLK: data analysis, data interpretation, critical revision. JWD: data 
analysis, data interpretation, critical revision.
Funding This research received no specific grant from any funding agency in the 
public, commercial or not-for-profit sectors.
Competing interests None declared.
ethics approval This study was approved by the Institutional Review Board for 
Community Medical Centers and the University of California, San Francisco-Fresno.
Provenance and peer review Not commissioned; externally peer reviewed.
open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work 
is properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2018. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
RefeRences
 1 Haan JM, Biffl W, Knudson MM, Davis KA, Oka T, Majercik S, Dicker R, Marder S, 
Scalea TM. Western Trauma Association Multi-Institutional Trials Committee. Splenic 
embolization revisited: a multicenter review. J Trauma 2004;56:542–7.
 2 Banerjee A, Duane TM, Wilson SP, Haney S, O’Neill PJ, Evans HL, Como JJ, Claridge 
JA. Trauma center variation in splenic artery embolization and spleen salvage: a 
multicenter analysis. J Trauma Acute Care Surg 2013;75:69–75.
 3 Miller PR, Chang MC, Hoth JJ, Mowery NT, Hildreth AN, Martin RS, Holmes JH, 
Meredith JW, Requarth JA. Prospective trial of angiography and embolization for 
all grade III to V blunt splenic injuries: nonoperative management success rate is 
significantly improved. J Am Coll Surg 2014;218:644–8.
 4 Zarzaur BL, Kozar R, Myers JG, Claridge JA, Scalea TM, Neideen TA, Maung AA, 
Alarcon L, Corcos A, Kerwin A, et al. The splenic injury outcomes trial: an American 
Association for the surgery of trauma multi-institutional study. J Trauma Acute Care 
Surg 2015;79:335–42.
 5 Bhullar IS, Frykberg ER, Siragusa D, Chesire D, Paul J, Tepas JJ, Kerwin AJ. 
Selective angiographic embolization of blunt splenic traumatic injuries in adults 
decreases failure rate of nonoperative management. J Trauma Acute Care Surg 
2012;72:1127–34.
 6 Bhullar IS, Tepas JJ, Siragusa D, Loper T, Kerwin A, Frykberg ER. To nearly come 
full circle: Nonoperative management of high-grade IV-V blunt splenic trauma is 
safe using a protocol with routine angioembolization. J Trauma Acute Care Surg 
2017;82:657–64.
 7 Weng J, Brown CV, Rhee P, Salim A, Chan L, Demetriades D, Velmahos GC. White 
blood cell and platelet counts can be used to differentiate between infection and 
the normal response after splenectomy for trauma: prospective validation. J Trauma 
2005;59:224–1080.
 8 Banerjee A, Kelly KB, Zhou HY, Dixon SD, Papana Dagiasis A, Quinn LM, Claridge 
JA. Diagnosis of infection after splenectomy for trauma should be based on lack of 
platelets rather than white blood cell count. Surg Infect 2014;15:221–6.
 9 Toutouzas KG, Velmahos GC, Kaminski A, Chan L, Demetriades D. Leukocytosis 
after posttraumatic splenectomy: a physiologic event or sign of sepsis? Arch Surg 
2002;137:924–9.
 10 Imbrogno BF, Ray CE. Splenic artery embolization in blunt trauma. Semin Intervent 
Radiol 2012;29:147–9.
 11 Shanmuganathan K, Mirvis SE, Boyd-Kranis R, Takada T, Scalea TM. Nonsurgical 
management of blunt splenic injury: use of CT criteria to select patients for splenic 
arteriography and potential endovascular therapy. Radiology 2000;217:75–82.
 12 Killeen KL, Shanmuganathan K, Boyd-Kranis R, Scalea TM, Mirvis SE. CT findings after 
embolization for blunt splenic trauma. J Vasc Interv Radiol 2001;12:209–14.
 13 Ekeh AP, McCarthy MC, Woods RJ, Haley E. Complications arising from splenic 
embolization after blunt splenic trauma. Am J Surg 2005;189:335–9.
 14 Wu SC, Chen RJ, Yang AD, Tung CC, Lee KH. Complications associated with 
embolization in the treatment of blunt splenic injury. World J Surg 2008;32:476–82.
 15 Schnüriger B, Inaba K, Konstantinidis A, Lustenberger T, Chan LS, Demetriades D. 
Outcomes of proximal versus distal splenic artery embolization after trauma: a 
systematic review and meta-analysis. J Trauma 2011;70:252–60.
